Young age at diagnosis is a negative prognostic factor for patients with early breast cancer, particularly those with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) breast cancer (1–3). Here, ERBB2 is linked to breast carcinoma.